NMRA — Neumora Therapeutics Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Neumora Therapeutics Inc (NMRA), worth $5.83M combined. Over the quarter 0 opened or added, 2 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Lunate | $3.61M | 1.80% | NO CHANGE |
| Renaissance | $2.15M | 0.00% | -9.1% |
| Quadrature | $67.36K | 0.00% | -53.6% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.